Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AkditalCAS:AKT -0.78%84 EV-to-FCF is -9.16 as of Jul. 16, 2026. GuruFocus rates CAS:AKT with a GF Score™ of 84/100 and a GF Value™ of MAD2,149.19 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 406 Healthcare Providers & Services companies, Akdital ranks worse than 246305.17% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Akdital's Enterprise Value is MAD18,919 Mil.
Akdital's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was MAD-2,066 Mil. Therefore, Akdital's EV-to-FCF for today is -9.16.
The historical rank and industry rank for Akdital's EV-to-FCF or its related term are showing as below:
CAS:AKT'
s EV-to-FCF Range Over the Past 10 Years
Min: -19.72 Med: -9.86 Max: -6.58
Current: -9.25
During the past 7 years, the highest EV-to-FCF of Akdital was -6.58. The lowest was -19.72. And the median was -9.86.
CAS:AKT's EV-to-FCF is ranked worse than 100% of 406
companies
in the Healthcare Providers & Services industry
Industry Median: 18.015
vs CAS:AKT: -9.25
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-07-16), Akdital's stock price is MAD1151.00.
Akdital's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was MAD31.336. Therefore, Akdital's PE Ratio (TTM) for today is 36.73.
Akdital (CAS:AKT) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Akdital's share price for today is MAD1151.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Akdital's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was MAD31.336.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Akdital EV-to-FCF Related Terms
Akdital EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Akdital's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Akdital's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Akdital EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Akdital's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Akdital's EV-to-FCF falls into.
Akdital's current Enterprise Value is MAD18,919 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Akdital's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was MAD-2,066 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Akdital (CAS:AKT) has a EV-to-FCF of -9.16 as of Jul. 16, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Akdital and its competitors. According to the industry distribution chart, Akdital ranks #999999 out of 406 companies in the Healthcare Providers & Services industry.
Is Akdital's EV-to-FCF too high?
Akdital's current EV-to-FCF is -9.16. Based on the distribution chart, Akdital ranks #999999 out of 406 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Akdital has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Akdital's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Akdital ranks #999999 out of 406 companies for EV-to-FCF. This places Akdital in the lower half of its industry. The industry median EV-to-FCF is 18.02. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.02, based on 406 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Akdital and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Akdital's current EV-to-FCF is -9.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akdital stock overvalued right now?
Based on GuruFocus' analysis, Akdital (CAS:AKT) is currently considered Possible Value Trap. The stock's GF Value™ is MAD2,149.19, compared to a current price of MAD1,151.00 — trading 46.4% below its estimated fair value. The current EV-to-FCF is -9.16. Akdital's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Akdital (CAS:AKT), the current EV-to-FCF is -9.16 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Akdital (CAS:AKT) Overvalued in 2026?
Based on GuruFocus' analysis, Akdital stock appears to be undervalued.
The current stock price of MAD1,151.00 is trading 46.4% below its estimated GF Value™ of MAD2,149.19.
GuruFocus considers Akdital to be Possible Value Trap.
Key valuation signals for CAS:AKT:
EV-to-FCF: -9.16
GF Value™: MAD2,149.19 vs. price of MAD1,151.00 (46.4% below fair value)
No single metric tells the full story. See the CAS:AKT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Akdital operates private healthcare clinics. The company offers healthcare services such as cardiac surgery, oncology, radiotherapy, intensive care, and neonatal care, providing patients with comprehensive care according to international standards.
84GF Score
Get the complete analysis for CAS:AKT
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAS:AKT has been successfully added to your 
